United States - English - NLM (National Library of Medicine)

exact-rx, inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 100 mg in 1 g - indications : sodium sulfacetemide 10% and sulfer 5% cleanser is indicated for he topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. contraindications : sodium sulfacetamide 10% & sulfer 5% cleanser is contraindicated in persons with know or suspected hypersensitivity to sulfonamides, sulfer or any other component of this preparation. sodium sulfacetamide 10% & sulfer %5% cleanser is not to be used by patients with kidney disease. caution : if redness or irritaiton occurs, discontinue use.

United States - English - NLM (National Library of Medicine)

medimetriks pharmaceuticals inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 90 mg in 1 g - sumadan® (sodium sulfacetamide 9% & sulfur 4.5%) wash is indicated for the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. sumadan® (sodium sulfacetamide 9% & sulfur 4.5%) wash are contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. sumadan® (sodium sulfacetamide 9% & sulfur 4.5%) wash is not to be used by patients with kidney disease.

United States - English - NLM (National Library of Medicine)

prugen, inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 80 mg in 1 ml - sulfacleanse® 8/4 (sodium sulfacetamide 8% & sulfur 4%) is indicated for the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. sulfacleanse® 8/4 (sodium sulfacetamide 8% & sulfur 4%) is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. sulfacleanse® 8/4 (sodium sulfacetamide 8% & sulfur 4%) is not to be used by patients with kidney disease.

United States - English - NLM (National Library of Medicine)

medimetriks pharmaceuticals inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 90 mg in 1 g - sumadan® (sodium sulfacetamide 9% & sulfur 4.5%) wash is indicated for the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. sumadan® (sodium sulfacetamide 9% & sulfur 4.5%) wash are contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. sumadan® (sodium sulfacetamide 9% & sulfur 4.5%) wash is not to be used by patients with kidney disease.

United States - English - NLM (National Library of Medicine)

asclemed usa, inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - indications and usage: sulfacetamide sodium ophthalmic solution usp, 10% is indicated for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms, and as an adjunctive in systemic sulfonamide therapy of trachoma: escherichia coli, staphylococcus aureus, streptococcus pneumoniae, streptococcus (viridans group), haemophilus influenzae, klebsiella species, and enterobacter species. topically applied sulfonamides do not provide adequate coverage against neisseria species, serratia marcescens and pseudomonas aeruginosa . a significant percentage of staphylococcal isolates are completely resistant to sulfa drugs. contraindications: sulfacetamide sodium ophthalmic solution is contraindicated in individuals who have a hypersensitivity to sulfonamides or to any ingredient of the preparation.

Ireland - English - HPRA (Health Products Regulatory Authority)

nicholas laboratories - sulfacetamide sodium hydrocortisone acetate - cream

United States - English - NLM (National Library of Medicine)

acella pharmaceuticals, llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 100 mg in 1 g - indications and usage: bp 10-1 wash is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. contraindications: bp 10-1 wash is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. bp 10-1 wash is not to be used by patients with kidney disease. pediatric use - safety and effectiveness in children under the age of 12 have not been established.

United States - English - NLM (National Library of Medicine)

acella pharmaceuticals, llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 100 mg in 1 ml - indications: bp cleansing wash is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. contraindications: bp cleansing wash is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. bp cleansing wash is not to be used by patients with kidney disease. pediatric use - safety and effectiveness in children under the age of 12 have not been established.

United States - English - NLM (National Library of Medicine)

biocomp pharma, inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 ml - this product is intended for topical application in the following scaling dermatoses: seborrheic dermatitis and seborrhea sicca (dandruff). it also is indicated for the treatment of secondary bacterial infections of the skin due to organisms susceptible to sulfonamides. this product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product. this product is not to be used by patients with kidney disease.

United States - English - NLM (National Library of Medicine)

mission pharmacal company - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 ml - this product is intended for topical application in the following scaling dermatoses: seborrheic dermatitis and seborrhea sicca (dandruff). it also is indicated for the treatment of secondary bacterial infections of the skin due to organisms susceptible to sulfonamides. this product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product. this product is not to be used by patients with kidney disease. general: nonsusceptible organisms, including fungi, may proliferate with the use of this preparation. although rare, sensitivity to sodium sulfacetamide may occur. therefore, caution and careful supervision should be observed when prescribing this drug for patients who may be prone to hypersensitivity to topical sulfonamides. if the use of this product produces signs of hypersensitivity or other untoward reactions, discontinue use of the preparation. patients should be carefully observed for possible local irritation or sensitization during long-term thera